Duodenal-Jejunal Bypass Improves Insulin Resistance by Enhanced Glucagon-Like Peptide-1 Secretion Through Increase of Bile Acids.

MLA

Kashihara, Hideya, et al. “Duodenal-Jejunal Bypass Improves Insulin Resistance by Enhanced Glucagon-Like Peptide-1 Secretion Through Increase of Bile Acids.” Hepato-Gastroenterology, vol. 61, no. 132, June 2014, pp. 1049–54. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=26158164&authtype=sso&custid=ns315887.

APA

Kashihara, H., Shimada, M., Kurita, N., Iwata, T., Sato, H., Yoshikawa, K., Miyatani, T., Takasu, C., Matsumoto, N., & Ishibashi, H. (2014). Duodenal-Jejunal Bypass Improves Insulin Resistance by Enhanced Glucagon-Like Peptide-1 Secretion Through Increase of Bile Acids. Hepato-Gastroenterology, 61(132), 1049–1054.

Chicago

Kashihara, Hideya, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Hirohiko Sato, Kozo Yoshikawa, Tomohiko Miyatani, Chie Takasu, Noriko Matsumoto, and Hiroki Ishibashi. 2014. “Duodenal-Jejunal Bypass Improves Insulin Resistance by Enhanced Glucagon-Like Peptide-1 Secretion Through Increase of Bile Acids.” Hepato-Gastroenterology 61 (132): 1049–54. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=26158164&authtype=sso&custid=ns315887.